GeneDx Holdings Corp. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
GeneDx Holdings Corp. (WGS) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$341.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-03
- GeneDx Holdings Corp. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$341.00K.
- GeneDx Holdings Corp. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$253.00K, a 437.33% decline year-over-year.
- GeneDx Holdings Corp. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was -$66.00K.
- GeneDx Holdings Corp. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $190.00K, a 58.61% decline year-over-year.
- GeneDx Holdings Corp. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $106.00K, a 73.83% decline from fiscal 2024.
- GeneDx Holdings Corp. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $405.00K, a 4.71% decline from fiscal 2023.
- GeneDx Holdings Corp. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $425.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$341.00K 10-Q · filed 2026-08-03 | -$594.00K 10-Q · filed 2026-08-03 | -$660.00K derived: sum of 3 quarters · filed 2026-08-03 | -$470.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$253.00K 10-Q · filed 2026-05-04 | -$319.00K derived: sum of 2 quarters · filed 2026-05-04 | -$129.00K derived: sum of 3 quarters · filed 2026-05-04 | -$222.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $124.00K derived: sum of 2 quarters · filed 2026-02-23 | $31.00K derived: sum of 3 quarters · filed 2026-08-03 | $106.00K 10-K · filed 2026-02-23 |
| 2025-09-30 | $190.00K 10-Q · filed 2025-10-28 | $97.00K derived: sum of 2 quarters · filed 2026-08-03 | $172.00K 10-Q · filed 2025-10-28 | $84.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | -$93.00K 10-Q · filed 2026-08-03 | -$18.00K 10-Q · filed 2026-08-03 | -$106.00K derived: sum of 3 quarters · filed 2026-08-03 | $353.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $75.00K 10-Q · filed 2026-05-04 | -$13.00K derived: sum of 2 quarters · filed 2026-05-04 | $446.00K derived: sum of 3 quarters · filed 2026-05-04 | $614.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $371.00K derived: sum of 2 quarters · filed 2026-02-23 | $539.00K derived: sum of 3 quarters · filed 2026-02-23 | $405.00K 10-K · filed 2026-02-23 |
| 2024-09-30 | $459.00K 10-Q · filed 2025-10-28 | $627.00K derived: sum of 2 quarters · filed 2025-10-28 | $493.00K 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $168.00K 10-Q · filed 2025-07-29 | $34.00K 10-Q · filed 2025-07-29 | ||
| 2023-12-31 | $425.00K 10-K · filed 2026-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |